Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0001055726-22-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-09 | 2022-03-08 | INO | Humeau Laurent | CSO | M - OptEx | — | +19.9K | 102.5K | +24% | — |
| D | 2022-03-09 | 2022-03-08 | INO | Humeau Laurent | CSO | F - Tax | $3.26 | -6,882 | 95.6K | -7% | -$22.4K |
| D | 2022-03-09 | 2022-03-08 | INO | Humeau Laurent | CSO | M - OptEx | $0.00 | -19.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-08 | M | A | 19,900 | — | 102,487 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Common | Common Stock | 2022-03-08 | F | D | 6,882 | $3.26 | 95,605 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-03-08 | M | D | 19,900 | $0.00 | 0 | D | — · — to — | 19,900 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares vested on March 8, 2020; 19,900 shares vested on March 8, 2021; 19,900 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |